- 4009 Hackney Springs Ln, Sachse, TX 75048
Women’s health lab billing runs on timing and intent like no other specialty. The same Pap smear pays differently as screening versus diagnostic. The same NIPT panel is covered by one payer and denied by another based on documented risk. Gestational screening only counts within the right pregnancy window. Generalist billers rarely track this nuance, and revenue loss compounds quietly until an audit reveals a costly monthly pattern.
Screening vs. Diagnostic Pap/Pelvic Coding Errors
NIPT Medical Necessity & Duplicate Testing Denials
HPV Co-Testing Age & Interval Mismatches
Maternal Serum Screening Panel Component Errors
Gestational Screening Timing Denials
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Medicare covers screening pelvic and clinical breast exams (G0101) and screening Pap smear collection (Q0091) every 24 months for average-risk patients and annually for patients meeting Medicare's specific high-risk criteria. TransLabs tracks each patient's risk classification and last screening date to ensure claims match Medicare's frequency rules before submission.
Coverage for cell-free DNA aneuploidy screening (81420, 81507) varies enormously by payer, some cover it for all pregnant patients regardless of age or risk, others require documented risk factors, and Medicare Advantage plans frequently deny it outright as not reasonable and necessary. TransLabs validates every NIPT claim against the specific payer's current policy before submission.
Many payers limit aneuploidy screening to one approach per pregnancy and restrict repeat NIPT testing within a rolling period, denying a second cell-free DNA screen ordered after an earlier negative result in the same pregnancy. TransLabs tracks each patient's prior screening history to flag orders that risk a duplicate-testing denial.
Coverage for HPV co-testing alongside cervical cytology depends on the patient's age and the interval since the last screening, and payer policies don't always match current clinical guidelines. TransLabs validates HPV co-testing claims against each payer's specific age and interval requirements.
Many women's preventive services, including well-woman visits, contraceptive counseling, and select screenings, are covered without cost-sharing under the Affordable Care Act's preventive services mandate when coded correctly. TransLabs codes these services to preserve the no-cost-sharing benefit for patients whenever the service qualifies.
Each Medicare Administrative Contractor and commercial payer maintains its own policy on which maternal serum screening components are covered and at what gestational age. TransLabs maintains live coverage databases and validates gestational-age-to-test linkage on every claim before submission.
The CLFS sets Medicare payment rates for women's health lab tests and updates annually on January 1, while laboratories meeting the applicable laboratory definition under PAMA carry mandatory private payer data reporting obligations. TransLabs monitors CLFS changes and tracks your PAMA obligations to ensure accurate, on-time compliance.
Most billing companies treat women’s health lab claims like any other outpatient testing, missing the screening-versus-diagnostic distinction, the gestational timing rules, and the payer-by-payer variation in NIPT coverage. TransLabs was built for laboratory billing exclusively, and our women’s health team tracks all three.
Dedicated billing specialist assigned to your practice or lab
Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks (screening/diagnostic mismatches, NIPT denials, timing errors)
Custom strategy tailored to your test menu and EHR/LIS software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you
A screening Pap smear, ordered as part of routine preventive care, uses Medicare’s G0101/G0124/Q0091 codes (for Medicare patients) or an age-appropriate preventive visit code with a screening diagnosis for commercial payers. A diagnostic Pap, ordered because of symptoms or an abnormal history, uses standard cytopathology CPT codes with a diagnostic ICD-10 code instead. Using the wrong set is one of the most common denial triggers in women’s health billing.
